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Background: AtrioVentricular (AV) and InterVentricular (VV) delay optimization can improve ventricular
function inCardiacResynchronizationTherapy (CRT) and isusually performedbymeansofechocardiography.
St Jude Medical has developed an automated algorhythm which calculates the optimal AV and VV delays
(QuickOpt™) based on Intracardiac ElectroGrams, (IEGM),within 2min. So far, the efﬁcacy of the algorhythm
has been tested acutely with standard lead position at right ventricular (RV) apex. Aim of this project is to
evaluate the algorhythm performance in the mid- and long-termwith RV lead located in mid-septum.
Methods: AV and VV delays optimization data were collected in 13 centers using both echocardiographic
and QuickOpt™ guidance in CRTD implanted patients provided with this algorhythm. Measurements of
the aortic Velocity Time Integral (aVTI) were performed with both methods in a random order at pre-
discharge, 6-month and 12-month follow-up.
Results: Fifty-three patients were studied (46 males; age 68 ± 10y; EF 28 ± 7%). Maximum aVTI obtained
by echocardiography at different AV delays, were compared with aVTI acquired at AV delays suggested by
QuickOpt. The AV Pearson correlations were 0.96 at pre-discharge, 0.95 and 0,98 at 6- and 12- month
follow-up respectively. After programming optimal AV, the same approach was used to compare echo-
cardiographic aVTI with aVTI corresponding to the VV values provided by QuickOpt. The VV Pearson
Correlation were 0,92 at pre-discharge, 0,88 and 0.90 at 6-month and 12- month follow-up respectively.
Conclusions: IEGM-based optimization provides comparable results with echocardiographic method
(maximum aVTI) used as reference with mid-septum RV lead location.
Copyright © 2016, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).rdiology, Turin, Italy.
ria).
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Although Cardiac Resynchronization Therapy (CRT) has become
a standard treatment in chronic heart failure patients with Left
Ventricular (LV) systolic dysfunction, intraventricular conduction
delay and NYHA class II to IV, despite optimal medical therapy [1],
about 30e40% of patients still do not to respond to treatment [2e8].
The role of sensed and paced atrio-ventricular (PV/AV) and inter-
ventricular (VV) delays optimization remains controversial. The
2013 ESC guidelines on CRT do not recommend a routine AV and VV
optimization, which should be restricted to non-responders and to
patients with ischemic heart disease [1e10]. Optimization has been
performed using echocardiography, which, however, is time- and
skill-costly and can be hampered by a relevant intra- and inter-
observer variability [11e13]. This fact has prompted a series of
alternative methods for optimization, among which Intracardiac
ElectroGraMs (IEGM)-based algorithms [14e16] have gained most
attention. The QuickOpt™ (St Jude Medical, ST Paul, MN, USA) is an
automatic IEGM-based algorithm incorporated in CRT devices,
validated for optimizing AV and VV delays [14,17,18]. However, no
serial assessment over time has been performed to test the relation
between IEGM- and echo-generated optimal values of AV, PV and
VV intervals. Furthermore, right ventricular (RV) lead has been
predominantly located at the apex, and the QuickOpt™ reliability in
“non-apical” RV pacing sites has not been highlighted yet.
The QuickSept study has been designed to evaluate the efﬁcacy
of QuickOpt™ algorithm in a population of patients implanted with
a CRT system with deﬁbrillator capabilities (CRT-D) with the RV
lead in a mid-septal position, at Hospital discharge at six-month
and at one-year follow-up, by comparing AV and VV intervals
calculated by IEGM with those determined by echocardiographic
(ECHO) measurements.
2. Materials and methods
2.1. Population
Between January 2011 and January 2012, in 13 Italian Labora-
tories 53 patients were implanted with a CRT-D system according
to current guidelines indications [19]. All patients gave written
informed consent. Baseline patients’ features are shown in Table 1.
Main inclusion criteria were: stable and safe placement of an
activeeﬁxation RV lead on mid-interventricular septum; achieve-
ment of an efﬁcacious LV intravenous pacing from a Coronary Sinus
(CS) branch. St Jude Medical (Saint Paul, Minnesota MN, USA)
manufactured CRT-D systems with QuickOpt™ algorithm were
implanted: models CD3211-36 Promote Plus, CD3215-36 Promote
Accel, CD3239-40 Promote Quadra, 3251-40 Unify Quadra and
3235-40 Unify, with the single or dual-coil active ﬁxation leads
Durata mod. 7120Q and 7122Q. Enrolment was accomplished atTable 1
Baseline features of study population (n ¼ 53). LVEF: Left Ventricular Ejection
Fraction; ESV: End Systolic Volume; EDV: End Diastolic Volume.
Baseline features Mean ± SD or %
Gender (M) 46 (86.8%)
Age (years) 68 ± 10
LVEF (%) 28 ± 7
ESV (ml) 148 ± 70
EDV (ml) 198 ± 79
Ischemic cardiomyopathy 47.2%
Dilated cardiomyopathy 39.6%
Hypertensive cardiomyopathy 3.8%
Myocardial non-compaction 1.9%
Etiology not reported 7.5%pre-discharge from hospital after recovery from implant. At hos-
pital discharge and after at each follow-up, AV, PV and VV intervals
were programmed as designated by the ECHO assessment.
2.2. Aims
Primary end-point was to evaluate the relationship between the
series of aortic ﬂow Velocity Time Integral (aVTI) values calculated
by the two methods at the PV, AV, and VV interval settings rec-
ommended by both the QuickOpt™ and the standard ECHO opti-
mization in CRT-D patients, at three index times: pre-discharge, at
6-month and at 12-month follow-ups.
Secondary end-point was to deﬁne the correlation between the
optimal AV, PV and VV intervals deﬁned by ECHO, using aVTI
measurements and by the QuickOpt™ algorithm, IEGM-based.
2.3. Right ventricular and left ventricular lead positioning
Deﬁbrillation lead was implanted in the mid interventricular
septum in all patients.
CS lead was implanted using current conventional technique.
2.4. Echocardiographic measurements
ECHO and Doppler measurements were performed at hospital
discharge, at 6-month and 12-month follow-ups. Transducer and
sample volume were maintained in the same position as far as
possible during the entire series of AV, PV or VV programming [20].
Acquisition of aortic Doppler ﬂow velocities was performed digi-
tally. The optimal AV, PV, and VV delay by the ECHO method was
deﬁned as the delay associated with the largest average aVTI. Aortic
VTI measurements were obtained in accordance with the American
Society of Echocardiography guidelines [12]. A random sample
(average 2 ECHO for each Laboratory at discharge) of echocardio-
graphic exams pre-discharge, 6months and one year follow-upwas
evaluated off-line for each center by a Core-lab. The reproducibility
in aVTI measurements was determined as the inter- and intra-
center (that is: between echocardiographers) using variability co-
efﬁcient (CV).
2.5. aVTI and IEGM acquisitions
AV and VV interval optimization was carried out by each
participating center by calculating the aVTI on pulsed Doppler of
transaortic ﬂow. Using the VTI method the best matching of AV and
VV intervals was determined at each patient’s evaluation. Trans-
ducer and sample volume were maintained in the same position as
far as possible during the entire series of AV/PV or VV programming
[12,20]. Acquisition of aortic Doppler ﬂow velocities was performed
digitally. With patients in a stable clinical condition, three aVTI
measurements for each combination of AV, PV and VV (see Table 2)
programmed values were performed 2 min after the programming
of delays, excluding both premature beats and post-premature
contraction beats. From the sampled aortic ﬂow, pre-ejections
components were excluded, which corresponded to atrial and
isovolumetric ventricular contractions. The sequence of acquisi-
tions of aVTI with different AV and VV intervals was single-blind
and randomly decided by the attending electrophysiologist, in or-
der to keep the echocardiographer unaware of the programmed
delay.
2.6. Statistical analysis
Categorical variables describing the patient population are
expressed as absolute numbers and percentages, while continuous
Table 2
aVTI measureswere carried out with different AV, PV and VV delays. The table shows
the delays used during Echocardiographic measurements.
aVTIa measures with DDD atrial rate >10bpm spontaneous rate:
QuickOpt AV/PVb QuickOpt VV
QuickOpt AV/PV ± 20 QuickOpt VV ± 10
QuickOpt AV/PV ± 40 QuickOpt VV ± 20
QuickOpt AV/PV ± 60 (max AV/PV ¼ 200 ms) QuickOpt VV ± 40
a aVTI: aortic Velocity Time Integral.
b AV/PV_Atrio-Ventricular Delay.
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medians (with quartiles) for continuous variables.
Nonparametric Wilcoxon-Mann-Whitney and Wilcoxon signed
rank (for paired data) tests were used for non-normally distributed
variables. The primary endpoint was assessed by means the linear
correlation analysis by the Pearson product-moment correlation
coefﬁcient to assess the agreement between the ECHO-based and
the IEGM-based aVTIs for each of the AV/PV, and VV delay
determinations.
The secondary endpoint was assessed by means the
BlandeAltman [21] plot method, to test whether the overlap be-
tween the series of values given by the two techniques was
congruent. It was deemed as clinically acceptable to have a differ-
ence not wider than 30 msec in measurements of AV and VV
intervals.
Intra and inter-observer reproducibility of echocardiographic
measurements were reported as CV calculated using the formula:
CV ¼ ¼ (SD/arithmetic mean of measurements)/100, where SD is
the standard deviation of residuals (measurement 1 -measurement
2) [21]. CV value less than 5% was considered to indicate a good
reproducibility.
The software Microsoft Ofﬁce Excel 2007 was employed for data
storage and analysis.
3. Results
3.1. Electrical results
Fifty-three patients were enrolled. Rv lead was in septal position
in all patients. Atrial lead was implanted in appendage in 98% of the
patients. LV lead was implanted in 26 (49%) patients in a lateral
vein, in 1(2%) in an antero-lateral vein, in 4 (7%) in a middle vein, in
10 (20%) in a postero vein and in 12 (22%) in a postero-lateral vein.
Leads electrical parameters were acceptable after implant pro-
cedure and stable at follow-up (Table 3). Neither RV lead
dislodgement nor failures in electrical therapies delivery nor
arrhythmic death occurred.
3.2. Comparison between aVTI after optimizing PV and AV intervals
by echocardiography and by QuickOpt™
Optimal mean PV and AV values, obtained from the best aVTI
which were calculated by both IEGM-based and echocardiographicTable 3
Left and Right Leads electrical measurements at pre-discharge, 6-month (6 m FU) and 12-
was found during the Study.
Pre-discharge (mean ± SD)
RVa wave amplitude (mV) 10.88 ± 4.76
RV Pacing threshold (V  0.5 ms) 0.56 ± 0.51
LVb Pacing threshold (V  0.5 ms) 1.16 ± 0.6
a RV: Right ventricle.
b LV:Left Ventricle.method, showed a good correlation at hospital discharge and at 6-
month and 12-month follow-up. Correlation coefﬁcients were al-
ways above 94% (Table 4). The close linear relationship between the
values of maximum aVTI calculated with both methods at
discharge and after 12 months is showed in Fig. 1.
3.3. Comparison between aVTI after optimizing interventricular
(VV) intervals by echocardiography and by QuickOpt™
At the optimized VV intervals, the values of aVTI calculated by
both IEGM and echocardiographic method showed a good corre-
lation, with a coefﬁcient above 88% at the three index times
(Table 5). The relationship between the maximum aVTI calculated
with both methods at discharge and at 12-month follow-up is
showed in Fig. 2.
As expected the overall difference between the best aVTI and
the worst aVTI is signiﬁcant for AV (p < 0.001), PV (p < 0.001) and
VV (p < 0.001). Different Delay produced signiﬁcant different in VTI
Values.
4. Secondary end point
4.1. Comparison between optimal PV/AV intervals measured by
echocardiographic method and by QuickOpt™
Using Bland-Altman plot analysis, in any single patient the
clinically acceptable correlation between echo- and IEGM-
generated PV/AV optimized measures showed a progressive
improvement. Cases where differences in mean’s variations were
less than 30 ms were 52% at discharge and became 61% and 65% at
six- and twelve-month follow-up (Fig. 3).
4.2. Comparison between optimal VV intervals measured by
echocardiographic method and by QuickOpt™
The analysis of values given by the two techniques, performed
using the BlandeAltman plot, demonstrated that the clinically
acceptable congruence between them was substantially stable
during the follow-up. The corresponding difference less than 30 ms
between the two techniques were 56% at discharge, and 51% and
48% at 6- and 12-month follow-up respectively (Fig. 4).
4.3. Intra and inter-observer reproducibility of echocardiographic
measurements
Intra and inter-observer reproducibility of aVTI measurements,
reported as coefﬁcient of variation (CV), are displayed in Table 6.
The aVTI determined at LVOT measurement resulted reproducible,
being both intra- and inter-observer CV less than 5% in all follow-
ups.
4.4. Discussion
In a selected population of CRT-D patients with a mid-septalmonth follow-Ups (12 m FU). No failure in sensing, pacing and deﬁbrillation therapy
6 m FU (mean ± SD) 12 m FU (mean ± SD)
10.05 ± 5.03 9.91 ± 5.28
0.69 ± 0.42 0.68 ± 0.46
1.5 ± 1 1.5 ± 1.18
Table 4
aVTIs obtained with optimal AV/PV intervals calculated with Echo-based and IEGM-based QuickOPt method at pre-discharge, 6-monthfollow-Up (6 m FU) and 12-month
follow-Up (12 m FU); Pearson correlation analysis showed a good correlation between aVTIs obtained with both methods; Median and quartiles (25, 75) of AV/PV Optimal
Delay; there aren’t signiﬁcant differences between the two methods.
aVTI (cm) Mean ± SD Pearson coefﬁcient value Optimal delays median; Interquartile 25; 75 (ms) P value
AV delay pre-discharge Max Echo 20.8 ± 6.7 0.96 170[130; 190] P ¼ 0.9
IEGM 19.2 ± 9.7 150 [150; 170]
PV delay pre-discharge Max Echo 23 ± 8 0.94 120[85; 150] P ¼ 0.4
IEGM 21.2 ± 7.3 110 [100; 130]
AV delay 6 m FU Max Echo 22 ± 6 0.95 160[142.5; 190] P ¼ 0.67
IEGM 20 ± 6 160[150; 170]
PV delay 6 m FU Max Echo 25 ± 8 0.94 120[100; 140] P ¼ 0.59
IEGM 23 ± 7 110[100; 120]
AV delay 12 m FU Max Echo 22.9 ± 8.8 0.98 165[150; 190] P ¼ 0.38
IEGM 21.7 ± 8 160[150; 170]
PV delay 12 m FU Max Echo 26 ± 10 0.97 110[80; 140] P ¼ 0.69
IEGM 24 ± 9 110[100; 120]
Fig. 1. Correlation between aVTI (cm) calculated with optimal AV/PV intervals optimized by Echo and QuickOpt™method’s at pre-discharge and at 12 month Follow up (upper line).
The correlation between the two methods is always good.
Table 5
aVTIs obtained with optimal VV intervals calculated with Echo-based and IEGM-based QuickOpt™ method at pre-discharge, 6-month follow-Up (6 m FU) and 12.month
follow-Up (12 m FU). Pearson correlation analysis showed a good correlation between aVTIs obtained with both methods.
aVTI (cm) Mean ± SD Pearson
VV delay pre-discharge Max Echo 23.2 ± 8 0.92
IEGM 20.8 ± 7.1
VV Delay 6 m FU Max Echo 24.9 ± 7.5 0.88
IEGM 21 ± 6.7
VV Delay 12 m FU Max Echo 25.9 ± 10 0.91
IEGM 22 ± 8
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at the optimized AV/PV and VV intervals as determined by ECHO
method and by QuickOpt™ algorithm -based method were quite
well correlated, and that this correlation was maintained in long-
term follow-ups. Previously published works have validated the
IEGM-based algorithm for optimizing AV and VV delays, in an acute
and single-time setting and with RV lead at the apex. Most pro-
spective, small sample and non-randomized studies have demon-
strated that the QuickOpt™ -generated acute optimization was
comparable with the ECHO-based one as far as long-term response
to CRT was concerned, and that the QuickOpt™ method resulted
faster and easier to perform than ECHO-guided optimization
[13e17]. On the other hand other studies was reached a discordant
conclusion, The FREEDOM [23] results presented at Heart Rhythm
Society in 2010 showed no statistically signiﬁcant differencebetween echo and QuickOpt approaches.
In Quicksept, ECHO aVTI was used for ECHO-based optimization
of AV and VV intervals. In the Pearson correlation analysis,
comparing aVTI values, which were obtained by measuring AV and
VV intervals by echocardiography and IEGM-based QuickOpt™ al-
gorithm, the level of correspondence resulted around 90% at all
three index times (above 90% at AV evaluation, above 88% at VV
evaluation), with a fairly linear correlation.
However, a further analysis by means of Bland-Altman plot on
ECHO-derived and QuickOpt™ egenerated data regarding AV in-
tervals found that, at most, only in 52% of cases at discharge, 61% at
6 months follow up and 65% at 12 months follow-up were the
percent difference between measurements supplied by the two
methods below 30 msec e the predeﬁned upper limit of clinical
insigniﬁcance. Moreover, when VV intervals were analyzed, this
Fig. 2. Correlation between aVTI (cm) calculated at the optimized VV intervals obtained by Echo and QuickOpt™method’s at pre-discharge and at 12-month follow-up (upper line).
The correlation between the two methods was always good.
Fig. 3. Bland-Altman plot of differences in optimal atrioventricular interval measured by echocardiography and by QuickOpt at Phd, 6 and 12-month follow-up. Grey zone indicate
average, upper and lower limit of agreement (1.13 msec ± 31 msec; IC 95% 61 msec þ 63 msec). Colored area indicates clinically acceptable margins of difference between the two
tecniques (0 ± 30 msec). Although there was no statistical difference between the two methods, the clinically acceptable margins of difference between them (0 ± 30 msec) showed
a low concordance (64%).
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This ﬁnding suggests that optimal aVTIs determined by the two
methods were similar evenwith a remarkable difference in AV and
VV intervals, and that, consequently, there could be a wide varia-
tions among the programmed settings in the same patients. In
measurements of VV intervals by the twomethods therewas a poor
correlation depending on the ventricle which was paced ﬁrst with
50% of discordance (Fig. 5).
Discrepancy between echo- and QuickOpt™ -calculated aVTIs
being fairly well correlated and corresponding AV and VV intervals
being scarcely correlated could be due to the fact that even wide
variations of AV and VV delays can elicit small hemodynamic effects
When we study AV delays, the hemodynamic effect can also be
inﬂuenced by the VV delay. The inter-ventricular and intra-
ventricular delays are inﬂuenced by different factors, too.
This might be caused in our opinion by the very short time
allowed for the CRT device to work with each predeﬁned setting ofAV and VV intervals (in our study 2 min, but in other study only
30 s). A sort of slower hemodynamic adaptation to mechanical
consequences of a certain programming could be invoked. It can be
also hypothesized that methods for measuring aVTI require a
longer period of pacing to produce measurable different hemody-
namic effects.
On the other hand, 2-min interval allowed before each aVTI
measurement represented a reasonable standard utilized in other
studies, and longer “adaptive” times would have been barely
manageable, due to the remarkable duration of each echocardio-
graphic examination.
In conclusion, previous reports on QuickOpt™ performance in
optimizing AV and VV intervals in acute settings and with apical
placement of RV lead were substantially conﬁrmed by our obser-
vations in Quicksept study, which demonstrated the same reli-
ability of QuickOpt™ in mid- and long-term follow-up when RV
lead had been placed exclusively in the mid-septum [14e18,22].
Fig. 4. Bland-Altman plot of differences in optimal VV interval measured by echocardiography and by QuickOpt at Phd, 6 and 12-month follow-up. Grey zone indicate average,
upper and lower limit of agreement (25 msec ± 33 msec; IC 95% 40 msec þ 90 msec). Colored area indicates clinically acceptable margins of difference between the two tecniques
(0 ± 30 msec). Although there was no statistical difference between the two methods, the clinically acceptable margins of difference between them (0 ± 30 msec) showed a low
concordance (56%).
Table 6
Variability coefﬁcient (mean), its standard deviation (þSD) and its range, between
both inter- and intra-center echocardiographic measurements of aVTI. All values are
less than 5%, demonstrating a good reproducibility between echocardiographic
examinations.
CV% SD Range
Pre-Discharge 4.7 þ1.05 2.9e6.6
6-Month follow-up 4.8 þ1.15 2.7e7.4
12-Month follow-up 4.3 þ0.6 3.2e5.5
CV: Variability coefﬁcient.
Fig. 5. Correlation of optimal VV intervals measured with ECHO and QuickOpt method.
In 50% of cases the ventricle paced ﬁrst was different. In this analysis 13 patients with
VV intervals equal to 0 msec as calculated by either method were excluded. Blue
colored area represents the conﬂict zones between the two methods. In general the
larger the advance of the left ventricle, the wider the error between the two methods.
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This study was a small prospective Registry with a limited
population: ﬁndings need conﬁrming on a wider scale and with a
randomized design. The criteria for response to CRT were mostly
clinical, but response was not used to further investigate into
optimizationmethods and no comparison between responders and
non-responders as regards optimization was attempted. AorticVTI
suffers fromwell-known intrinsic limitations for optimizing AV/VV
intervals [24]: other authors have proposed other indices, among
which the maximal VTI of mitral inﬂow has gained most attention
[25]. On the other hand, there was no clue that aVTI use hampered
either of the methods taken into consideration unequally, and its
limits can be supposed not to have altered substantially the results
of methods’ comparison.Author’s disclosure
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